463 related articles for article (PubMed ID: 22954655)
1. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
[TBL] [Abstract][Full Text] [Related]
2. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.
Ali M; Sur D; You YA; Kanungo S; Sah B; Manna B; Puri M; Wierzba TF; Donner A; Nair GB; Bhattacharya SK; Dhingra MS; Deen JL; Lopez AL; Clemens J
Clin Infect Dis; 2013 Apr; 56(8):1123-31. PubMed ID: 23362293
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
Sur D; Lopez AL; Kanungo S; Paisley A; Manna B; Ali M; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Donner A; Ganguly NK; Nair GB; Bhattacharya SK; Clemens JD
Lancet; 2009 Nov; 374(9702):1694-702. PubMed ID: 19819004
[TBL] [Abstract][Full Text] [Related]
4. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.
Ali M; Emch M; von Seidlein L; Yunus M; Sack DA; Rao M; Holmgren J; Clemens JD
Lancet; 2005 Jul 2-8; 366(9479):44-9. PubMed ID: 15993232
[TBL] [Abstract][Full Text] [Related]
5. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
[TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.
Franke MF; Ternier R; Jerome JG; Matias WR; Harris JB; Ivers LC
Lancet Glob Health; 2018 Sep; 6(9):e1028-e1035. PubMed ID: 30103980
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.
Ali M; Emch M; Yunus M; Sack D; Lopez AL; Holmgren J; Clemens J
Pediatr Infect Dis J; 2008 Jan; 27(1):33-7. PubMed ID: 18162935
[TBL] [Abstract][Full Text] [Related]
8. Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity.
Emch M; Ali M; Park JK; Yunus M; Sack DA; Clemens JD
Int J Epidemiol; 2006 Aug; 35(4):1044-50. PubMed ID: 16723370
[TBL] [Abstract][Full Text] [Related]
9. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
Qadri F; Wierzba TF; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Asaduzzaman M; Akter A; Khan A; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Islam T; Chowdhury AI; Rahman A; Siddique SA; You YA; Kim DR; Siddik AU; Saha NC; Kabir A; Cravioto A; Desai SN; Singh AP; Clemens JD
N Engl J Med; 2016 May; 374(18):1723-32. PubMed ID: 27144848
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.
Qadri F; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Begum YA; Bhuiyan TR; Chowdhury MI; Uddin MJ; Khan JAM; Chowdhury AI; Rahman A; Siddique SA; Asaduzzaman M; Akter A; Khan A; Ae You Y; Siddik AU; Saha NC; Kabir A; Riaz BK; Biswas SK; Begum F; Unicomb L; Luby SP; Cravioto A; Clemens JD
Lancet; 2015 Oct; 386(10001):1362-1371. PubMed ID: 26164097
[TBL] [Abstract][Full Text] [Related]
12. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial.
Qadri F; Ali M; Lynch J; Chowdhury F; Khan AI; Wierzba TF; Excler JL; Saha A; Islam MT; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Khan IA; Kabir A; Riaz BK; Akter A; Khan A; Asaduzzaman M; Kim DR; Siddik AU; Saha NC; Cravioto A; Singh AP; Clemens JD
Lancet Infect Dis; 2018 Jun; 18(6):666-674. PubMed ID: 29550406
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
Ali M; Qadri F; Kim DR; Islam MT; Im J; Ahmmed F; Khan AI; Zaman K; Marks F; Kim JH; Clemens JD
Lancet Infect Dis; 2021 Oct; 21(10):1407-1414. PubMed ID: 34146473
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
[TBL] [Abstract][Full Text] [Related]
16. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
Schaetti C; Weiss MG; Ali SM; Chaignat CL; Khatib AM; Reyburn R; Duintjer Tebbens RJ; Hutubessy R
PLoS Negl Trop Dis; 2012; 6(10):e1844. PubMed ID: 23056660
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.
Wierzba TF; Kar SK; Mogasale VV; Kerketta AS; You YA; Baral P; Khuntia HK; Ali M; Kim YH; Rath SB; Bhattachan A; Sah B
Vaccine; 2015 May; 33(21):2463-9. PubMed ID: 25850019
[TBL] [Abstract][Full Text] [Related]
18. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
[TBL] [Abstract][Full Text] [Related]
19. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.
Vu DT; Hossain MM; Nguyen DS; Nguyen TH; Rao MR; Do GC; Naficy A; Nguyen TK; Acosta CJ; Deen JL; Clemens JD; Dang DT
J Health Popul Nutr; 2003 Dec; 21(4):304-8. PubMed ID: 15043004
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan.
Porta MI; Lenglet A; de Weerdt S; Crestani R; Sinke R; Frawley MJ; Van Herp M; Zachariah R
Trans R Soc Trop Med Hyg; 2014 Dec; 108(12):810-5. PubMed ID: 25311798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
